Whitepapers

Manual inventory processes once cost Texas Children’s Hospital millions annually in drug waste and inefficiencies. To close costly blind spots and gain control over medication use, the system implemented RFID-enabled pharmacy automation. The result: real-time visibility into inventory levels, expiration…

Musculoskeletal (MSK) conditions now cost the U.S. more than $420 billion, yet many payer-led interventions fail to engage patients early enough to prevent low-value procedures and rising costs. This new report from TailorCare shows what happens when patients are guided…

Oregon Health & Science University runs 53 ORs across 4 sites and performs nearly 39,000 cases a year. With financial pressure and rising surgical volume, perioperative leaders needed a faster, more reliable way to staff rooms and sustain morale.  This…

Regional anesthesia is moving from “nice to have” to a core component of orthopedic care by easing pain, accelerating recovery and expanding what’s possible in outpatient surgery. Yet many groups leave clinical and financial value on the table due to…

Nearly half of hospital revenue cycle leaders say denials are their top financial concern — outranking labor shortages, reimbursement cuts and analytics gaps. While many teams focus on rework, high-performing hospitals are looking upstream. This short report offers 10 strategies…

How proactive CFOs are protecting revenue, strengthening compliance, and preparing for sweeping Medicaid changes Q1 2026 is coming fast—and with it, Medicaid cuts, tighter margins, and new documentation and compliance requirements. Hospitals in ACA expansion states and rural communities face…

Managing locum tenens at scale is rarely efficient. For one Mid-Atlantic academic medical center, a fragmented approach led to high costs, siloed departments and internal competition for providers. But a centralized, vendor-neutral strategy changed everything. By overhauling its locum tenens…

More than 200 industry leaders have spoken: the 2025 Trends in Specialty Drug Benefits Report, co-sponsored by Genentech and Pharmaceutical Strategies Group (PSG), is here. This executive summary captures how payers are resetting specialty drug strategies and what that means…

Many self-funded organizations are still making high-stakes benefits decisions without timely, actionable data. That gap is becoming more costly as employer healthcare expenses are projected to rise 8% in 2025, marking the steepest increase in a decade. This report examines…

Hospitals and health systems are losing patients, revenue and community confidence to months-long behavioral health waitlists. Children’s Wisconsin reduced a 600-patient child psychiatry waitlist to zero by expanding access to subspecialists without capital buildouts or year-long recruitment cycles. This report…